Yes, IGF-1 LR3 can lead to abnormal bone or tissue growth if used excessively
The possible side effects of using compounded tirzepatide include: Indigestion Bloating or gas Constipation Decreased appetite Diarrhea Increased heart rate General fatigue Upset stomach Heartburn or acid reflux Stomach pain Vomiting There can also be some reactions at the injection side, like pain, bruising, irritation, itching, or rashes
Many commercial and Medicare plans now cover GLP-1 medications for weight management, but prior authorization and documentation of medical necessity are typically required
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF
George, evidence-based treatments such as semaglutide and tirzepatide help many patients lose 1521% of their total body weight (when using FDA-approved medications), resulting in meaningful improvements in long-term health
The proposal is written to take effect on Jan